Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

NCT01472627 · clinicaltrials.gov ↗

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

PROCEDURE: Blood draws

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]